Molecule
Sunitinib
15 brands of Sunitinib in stock, compared side by side.
We stock 15 brands of Sunitinib (capsule; 12.5 mg, 25 Mg, and 50 Mg). The lowest per-unit price is USD $ 0.75, for Sutykine 12.5 Mg Capsule. Every brand listed is prescription-only: you can upload your prescription at checkout or from your account.
| Brand | Strength | Pack | Price | Per unit | Availability |
|---|---|---|---|---|---|
| Mitant 12.5 Mg Capsule | 12.5 mg | 7 Capsules | USD $ 12.00 | USD $ 1.71 | In stock |
| Sutykine 12.5 Mg Capsule | 12.5 mg | 28 Capsules | USD $ 21.00 | USD $ 0.75 | In stock |
| Svitinib 12.5 Mg Capsule | 12.5 mg | 28 Capsules | USD $ 23.00 | USD $ 0.82 | In stock |
| Sugistran 12.5 Mg Capsule | 12.5 mg | 28 Capsules | USD $ 25.00 | USD $ 0.89 | In stock |
| Tunib 12.5 Mg Capsule | 12.5 mg | 28 Capsules | USD $ 35.00 | USD $ 1.25 | In stock |
| Sutent 12.5 Mg Capsule | 12.5 mg | 7 Capsules | USD $ 154.03 | USD $ 22.00 | In stock |
| Mitant 25 Mg Capsule | 25 Mg | 7 Capsules | USD $ 24.00 | USD $ 3.43 | In stock |
| Sutykine 25 Mg Capsule | 25 Mg | 28 Capsules | USD $ 42.00 | USD $ 1.50 | In stock |
| Sugistran 25 Mg Capsule | 25 Mg | 28 Capsules | USD $ 45.00 | USD $ 1.61 | In stock |
| Svitinib 25 Mg Capsule | 25 Mg | 28 Capsules | USD $ 46.00 | USD $ 1.64 | In stock |
| Tunib 25 Mg Capsule | 25 Mg | 28 Capsules | USD $ 66.00 | USD $ 2.36 | In stock |
| Sutykine 50 Mg Capsule | 50 Mg | 7 Capsules | USD $ 84.00 | USD $ 12.00 | In stock |
| Sugistran 50 Mg Capsule | 50 Mg | 28 Capsules | USD $ 85.00 | USD $ 3.04 | In stock |
| Svitinib 50 Mg Capsule | 50 Mg | 28 Capsules | USD $ 92.00 | USD $ 3.29 | In stock |
| Tunib 50 Mg Capsule | 50 Mg | 28 Capsules | USD $ 130.00 | USD $ 4.64 | In stock |
About Sunitinib
Sunitinib is an oral multi-targeted tyrosine kinase inhibitor (TKI) used to treat advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumours (GIST) after imatinib failure, and progressive pancreatic neuroendocrine tumours. It works by blocking VEGFR, PDGFR, KIT, FLT3, and RET receptors, inhibiting both tumour cell growth and the blood vessel formation tumours need to survive.
Originally marketed as Sutent, sunitinib is taken orally on a four-weeks-on, two-weeks-off schedule or as a continuous daily dose. It was among the first TKIs to demonstrate improved survival in metastatic renal cell carcinoma. Indian generics are available in 12.5 mg, 25 mg, and 50 mg capsule strengths.
At a glance
- Brands in stock
- 15
- Strengths
- 12.5 mg / 25 Mg / 50 Mg
- From
- USD $ 12.00